Claraphi Advisory Network, LLC Meira G Tx Holdings PLC Transaction History

Claraphi Advisory Network, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.55 - $11.25 $3,020 - $4,500	-400 Reduced 0.42%	93,836 $789,000
Q2 2022 Jul 19, 2022	SELL	$6.8 - $14.23 $34,000 - $71,150	-5,000 Reduced 5.04%	94,236 $713,000
Q1 2022 May 12, 2022	BUY	$13.42 - $23.38 $65,771 - $114,585	4,901 Added 5.2%	99,236 $1.37 Million
Q4 2021 Feb 07, 2022	SELL	$12.78 - $23.74 $1,584 - $2,943	-124 Reduced 0.13%	94,335 $2.24 Million
Q3 2021 Nov 15, 2021	SELL	$11.73 - $16.08 $117 - $160	-10 Reduced 0.01%	94,459 $1.25 Million
Q2 2021 Aug 16, 2021	SELL	$12.85 - $16.2 $29,143 - $36,741	-2,268 Reduced 2.34%	94,469 $1.46 Million
Q1 2021 Apr 30, 2021	BUY	$13.84 - $17.8 $69,200 - $89,000	5,000 Added 5.45%	96,737 $1.4 Million
Q4 2020 Feb 05, 2021	SELL	$12.4 - $17.6 $101,518 - $144,091	-8,187 Reduced 8.19%	91,737 $1.39 Million
Q2 2020 Aug 14, 2020	BUY	$11.79 - $15.97 $12,662 - $17,151	1,074 Added 1.09%	99,924 $1.25 Million
Q1 2020 May 15, 2020	BUY	$9.31 - $21.24 $739,651 - $1.69 Million	79,447 Added 409.46%	98,850 $1.33 Million
Q4 2019 Feb 13, 2020	BUY	$13.91 - $21.48 $269,895 - $416,776	19,403 New	19,403 $388,000

100

45.4M

19.2K

31K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $288M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Claraphi Advisory Network, LLC with notifications on news.